

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+13.86%
-4.42%
+2.74%
-0.30%
-2.79%
ARTL
Artelo Biosciences
$3.10
Strengths

Earnings are forecast to grow
Chart
$4.49 (-30.96%)
$8.35 (-62.87%)
$1.2 (+158.33%)
$1.04 (+198.08%)
ARTL has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

Low volume

High volatilty

ARTL overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
ARTL Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ARTL Street view is not attractive and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is ARTL current stock price?
What are ARTL stock strengths?
What risks are associated with ARTL stock?
When is ARTL next earnings report?
What is ARTL market cap and volume?
What is ARTL's current Stock IQ?
Should I buy ARTL stock right now?
Is ARTL a Strong Buy right now?
What does a 'Strong Buy' rating mean for ARTL?
What does a 'Strong Sell' rating mean for ARTL?
What factors influence ARTL's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+13.86%
-4.42%
+2.74%
-0.30%
-2.79%
ARTL
Artelo Biosciences
Current Price
$3.10
Stock Insights
Strengths

Earnings are forecast to grow
Chart
$4.49 (-30.96%)
$8.35 (-62.87%)
$1.2 (+158.33%)
$1.04 (+198.08%)
ARTL Analysts Opinion
ARTL Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
ARTL Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ARTL Street view is not attractive and have negative views on the near-term outlook
ARTL has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

Low volume

High volatilty

Average key support and resistance price levels.
ARTL Latest Analysis
Artelo Biosciences Announces Expanded Clinical Data to be Presented on both ART26.12 and ART27.13 at the 8th Annual Cannabinoid & Endocannabinoid Drug Development Summit. ART26.12 Phase 1 Data Demonstrated No Safety Concerns Predictable Linear Plasma Exposure and Options for Dosing in Either Fed or Fasted Conditions
Wed Oct 15, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ARTL Stock trends
ARTL Stock performance
ARTL Stock analysis
ARTL investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.